Invariant natural killer T cells: Linking inflammation and neovascularization in human atherosclerosis
Open Access
- 2 September 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 40 (11) , 3268-3279
Abstract
Atherosclerosis, a chronic inflammatory lipid storage disease of large arteries, is complicated by cardiovascular events usually precipitated by plaque rupture or erosion. Inflammation participates in lesion progression and plaque rupture. Identification of leukocyte populations involved in plaque destabilization is important for effective prevention of cardiovascular events. This study investigates CD1d‐expressing cells and invariant NKT cells (iNKT) in human arterial tissue, their correlation with disease severity and symptoms, and potential mechanisms for their involvement in plaque formation and/or destabilization. CD1d‐expressing cells were present in advanced plaques in patients who suffered from cardiovascular events in the past and were most abundant in plaques with ectopic neovascularization. Confocal microscopy detected iNKT cells in plaques, and plaque‐derived iNKT cell lines promptly produced proinflammatory cytokines when stimulated by CD1d‐expressing APC‐presenting α‐galactosylceramide lipid antigen. Furthermore, iNKT cells were diminished in the circulating blood of patients with symptomatic atherosclerosis. Activated iNKT cell‐derived culture supernatants showed angiogenic activity in a human microvascular endothelial cell line HMEC‐1‐spheroid model of in vitro angiogenesis and strongly activated human microvascular endothelial cell line HMEC‐1 migration. This functional activity was ascribed to IL‐8 released by iNKT cells upon lipid recognition. These findings introduce iNKT cells as novel cellular candidates promoting plaque neovascularization and destabilization in human atherosclerosis.Keywords
This publication has 48 references indexed in Scilit:
- Subendothelial Lipoprotein Retention as the Initiating Process in AtherosclerosisCirculation, 2007
- Plaque Neovascularization and Antiangiogenic Therapy for AtherosclerosisJACC, 2007
- T Cells in AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Do metalloproteinases destabilize vulnerable atherosclerotic plaques?Current Opinion in Lipidology, 2006
- Lipid metabolism, atherogenesis and CD1-restricted antigen presentationTrends in Molecular Medicine, 2006
- Atherosclerotic Plaque Progression and Vulnerability to RuptureArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Arterial Neovascularization and Inflammation in Vulnerable PatientsCirculation, 2004
- Metalloproteinases in Development and Progression of Vascular DiseasePathophysiology of Haemostasis and Thrombosis, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002